Literature DB >> 29091080

Campylobacter jejuni impairs sodium transport and epithelial barrier function via cytokine release in human colon.

R Bücker, S M Krug, V Moos, C Bojarski, M R Schweiger, M Kerick, A Fromm, S Janßen, M Fromm, N A Hering, B Siegmund, T Schneider, C Barmeyer, J D Schulzke.   

Abstract

This corrects the article DOI: 10.1038/mi.2017.66.

Entities:  

Year:  2017        PMID： 29091080     DOI： 10.1038/mi.2017.78

Source DB:  PubMed          Journal:  Mucosal Immunol        ISSN： 1933-0219            Impact factor:   7.313


  12 in total

Review 1.  Human Campylobacteriosis-A Serious Infectious Threat in a One Health Perspective.

Authors:  Markus M Heimesaat; Steffen Backert; Thomas Alter; Stefan Bereswill
Journal:  Curr Top Microbiol Immunol       Date:  2021       Impact factor: 4.291

2.  Vitamin D in Acute Campylobacteriosis-Results From an Intervention Study Applying a Clinical Campylobacter jejuni Induced Enterocolitis Model.

Authors:  Soraya Mousavi; Fábia Daniela Lobo de Sá; Jörg-Dieter Schulzke; Roland Bücker; Stefan Bereswill; Markus M Heimesaat
Journal:  Front Immunol       Date:  2019-09-03       Impact factor: 7.561

3.  Curcumin Mitigates Immune-Induced Epithelial Barrier Dysfunction by Campylobacter jejuni.

Authors:  Fábia Daniela Lobo de Sá; Eduard Butkevych; Praveen Kumar Nattramilarasu; Anja Fromm; Soraya Mousavi; Verena Moos; Julia C Golz; Kerstin Stingl; Sophie Kittler; Diana Seinige; Corinna Kehrenberg; Markus M Heimesaat; Stefan Bereswill; Jörg-Dieter Schulzke; Roland Bücker
Journal:  Int J Mol Sci       Date:  2019-09-28       Impact factor: 5.923

4.  Preclinical Evaluation of Oral Urolithin-A for the Treatment of Acute Campylobacteriosis in Campylobacter jejuni Infected Microbiota-Depleted IL-10-/- Mice.

Authors:  Soraya Mousavi; Dennis Weschka; Stefan Bereswill; Markus M Heimesaat
Journal:  Pathogens       Date:  2020-12-23

5.  Resveratrol Prevents Campylobacter jejuni-Induced Leaky gut by Restoring Occludin and Claudin-5 in the Paracellular Leak Pathway.

Authors:  F D Lobo de Sá; M M Heimesaat; S Bereswill; P K Nattramilarasu; J D Schulzke; R Bücker
Journal:  Front Pharmacol       Date:  2021-04-15       Impact factor: 5.810

6.  Treatment with the Probiotic Product Aviguard® Alleviates Inflammatory Responses during Campylobacter jejuni-Induced Acute Enterocolitis in Mice.

Authors:  Markus M Heimesaat; Dennis Weschka; Soraya Mousavi; Stefan Bereswill
Journal:  Int J Mol Sci       Date:  2021-06-22       Impact factor: 5.923

7.  Garlic Essential Oil as Promising Option for the Treatment of Acute Campylobacteriosis-Results from a Preclinical Placebo-Controlled Intervention Study.

Authors:  Markus M Heimesaat; Soraya Mousavi; Dennis Weschka; Stefan Bereswill
Journal:  Microorganisms       Date:  2021-05-25

8.  Tilivalline- and Tilimycin-Independent Effects of Klebsiella oxytoca on Tight Junction-Mediated Intestinal Barrier Impairment.

Authors:  Nina A Hering; Anja Fromm; Roland Bücker; Gregor Gorkiewicz; Ellen Zechner; Christoph Högenauer; Michael Fromm; Jörg-Dieter Schulzke; Hanno Troeger
Journal:  Int J Mol Sci       Date:  2019-11-08       Impact factor: 5.923

Review 9.  Novel Clinical Campylobacter jejuni Infection Models Based on Sensitization of Mice to Lipooligosaccharide, a Major Bacterial Factor Triggering Innate Immune Responses in Human Campylobacteriosis.

Authors:  Soraya Mousavi; Stefan Bereswill; Markus M Heimesaat
Journal:  Microorganisms       Date:  2020-03-28

10.  Peroral Clove Essential Oil Treatment Ameliorates Acute Campylobacteriosis-Results from a Preclinical Murine Intervention Study.

Authors:  Stefan Bereswill; Soraya Mousavi; Dennis Weschka; Agnes Buczkowski; Sebastian Schmidt; Markus M Heimesaat
Journal:  Microorganisms       Date:  2021-03-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.